U.S. Vaccines Market by Type (Live Attenuated, mRNA, Viral Vectors, Toxoid, and Others), by Route of Administration (Parenteral and Oral), by Disease Indication (Viral Diseases {Hepatitis, Influenza, Human Papillomavirus, Herpes Zoster, and Others}, and Bacterial Diseases {Meningococcal Disease, Pneumococcal Disease and Others}), by Age Group (Pediatrics and Adults), by Distribution Channel (Hospital & Retail Pharmacies, Government Suppliers, and Others), by United states (Northeast, Southeast, Midwest, Southwest, West) Forecast 2024-2032
The U.S. Vaccines Market size was valued at USD 34.37 USD Billion in 2023 and is projected to reach USD 59.67 USD Billion by 2032, exhibiting a CAGR of 8.2 % during the forecast period. The word "vaccine" is formed from an adaptation of the word "Vacca" meaning cow, that's the prior call of the virus "vaccinia". It is an antidote that is composed of antibodies, lymphocytes, or mRNA which is particularly applied to keep away from illnesses. It typically is composed of both weakened and killed pathogenic microorganisms or their key components – proteins or sugars. This facilitates the immune system to determine a reaction to the unique germs, viruses, and bacteria. When a new pathogen or disorder enters our body, it's far the antigen on host cells that acknowledges their "non-self" nature and induces the production of B-lymphocyte unique antibodies that capture those antigens and doubtlessly spoil the invading pathogen. There are six categories of vaccines: attenuated virus (live or attenuated vaccine), inactivated or killed(inactivated vaccine), subunit (toxoid vaccine), viral vector (toxoid vaccine), and mRNA (mRNA vaccines). The US vaccine marketplace is critical for public health considering those preventive measures restrict spread of the communicable diseases; in addition lower with the severity with which character can be affected.
Our U.S. Vaccines Market Report provides comprehensive coverage of the industry, including:
By Type:
By Route of Administration:
By Disease Indication:
By Age Group:
By Distribution Channel:
Aspects | Details |
---|---|
Study Period | 2018-2032 |
Base Year | 2023 |
Estimated Year | 2024 |
Forecast Period | 2024-2032 |
Historical Period | 2018-2023 |
Growth Rate | CAGR of % from 2018-2032 |
Segmentation |
|
Office no. A 5010, fifth floor, Solitaire Business Hub, Near Phoenix mall, Pune, Maharashtra 411014
Craig Francis
Business Development Head
+44 1223 92 666
sales@advancemarketanalytics.com
get latest updates and offers.